The selective impact of transgenically expressed glucocorticoid receptor on T cells

Autoimmunity

Volumn 48, Issue 2, 2015, Pages 117-124

  Yakimchuk, Konstantin ^a   Chen, Liying ^a   Hasni, Mohammad Sharif ^a   Okret, Sam ^a   Jondal, Mikael ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Glucocorticoids; microarray; NK cells; T cells; tumor model

Indexed keywords

CD39 ANTIGEN; CD4 ANTIGEN; CD8 ANTIGEN; CORTICOSTERONE; GLUCOCORTICOID; GLUCOCORTICOID RECEPTOR; INTERLEUKIN 2 RECEPTOR ALPHA; INTERLEUKIN 2 RECEPTOR BETA; INTERLEUKIN 33; INTERLEUKIN 7; MESSENGER RNA; PROTEIN KINASE LCK; PROTEIN KINASE ZAP 70; TRANSCRIPTION FACTOR FOXP3; BIOLOGICAL MARKER; BTLA PROTEIN, MOUSE; FORKHEAD TRANSCRIPTION FACTOR; FOXP3 PROTEIN, MOUSE; GLUCOCORTICOID INDUCED TUMOR NECROSIS FACTOR RECEPTOR; IMMUNOGLOBULIN RECEPTOR; LEUKOCYTE ANTIGEN; PDCD1 PROTEIN, MOUSE; PROGRAMMED DEATH 1 RECEPTOR; TNFRSF18 PROTEIN, MOUSE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL EXPANSION; CELL KILLING; CELL POPULATION; CONTROLLED STUDY; DENDRITIC CELL; DOWN REGULATION; GENE OVEREXPRESSION; IMMUNE RESPONSE; IN VITRO STUDY; IN VIVO STUDY; LYMPHOCYTE FUNCTION; LYMPHOKINE ACTIVATED KILLER CELL; MALE; MICROARRAY ANALYSIS; MOUSE; NATURAL KILLER CELL; NATURAL KILLER T CELL; NONHUMAN; PHENOTYPE; PROTEIN EXPRESSION; RAT; REGULATORY T LYMPHOCYTE; SPLEEN CELL; T LYMPHOCYTE; T LYMPHOCYTE SUBPOPULATION; TISSUE DISTRIBUTION; TRANSGENIC MOUSE; ANIMAL; C57BL MOUSE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETICS; IMMUNOLOGY; IMMUNOPHENOTYPING; LYMPHOCYTE COUNT; METABOLISM; PATHOLOGY; PRIMARY CELL CULTURE; SPLEEN; T CELL LYMPHOMA;

ANIMALS; ANTIGENS, CD; BIOMARKERS; FORKHEAD TRANSCRIPTION FACTORS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; GLUCOCORTICOID-INDUCED TNFR-RELATED PROTEIN; IMMUNOPHENOTYPING; KILLER CELLS, NATURAL; LYMPHOCYTE COUNT; LYMPHOMA, T-CELL; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; NATURAL KILLER T-CELLS; PRIMARY CELL CULTURE; PROGRAMMED CELL DEATH 1 RECEPTOR; RATS; RECEPTORS, GLUCOCORTICOID; RECEPTORS, IMMUNOLOGIC; SPLEEN; T-LYMPHOCYTE SUBSETS;

EID: 84924974912     PISSN: 08916934     EISSN: 1607842X     Source Type: Journal    
DOI: 10.3109/08916934.2014.959164     Document Type: Article

References (53)

1. Baschant, U., and J. Tuckermann. 2010. The role of the glucocorticoid receptor in inflammation and immunity. J. Steroid Biochem. Mol. Biol. 120: 69-75.
2. Zen, M., M. Canova, C. Campana, et al. 2011. The kaleidoscope of glucorticoid effects on immune system. Autoimmun. Rev. 10: 305-310.
3. Drouin, J., Y. L. Sun, S. Tremblay, et al. 1992. Homodimer formation is rate-limiting for high affinity DNA binding by glucocorticoid receptor. Mol. Endocrinol. 6: 1299-1309.
4. Buttgereit, F., and A. Scheffold. 2002. Rapid glucocorticoid effects on immune cells. Steroids 67: 529-534.
5. Distelhorst, C. W. 2002. Recent insights into the mechanism of glucocorticosteroid-induced apoptosis. Cell Death Differ. 9: 6-19.
6. Jondal, M., A. Pazirandeh, and S. Okret. 2004. Different roles for glucocorticoids in thymocyte homeostasis? Trends. Immunol. 25: 595-600.
7. Herold, M. J., K. G. McPherson, and H. M. Reichardt. 2006. Glucocorticoids in T cell apoptosis and function. Cell. Mol. Life. Sci. 63: 60-72.
8. Qiao, S., L. Chen, S. Okret, and M. Jondal. 2008. Age-related synthesis of glucocorticoids in thymocytes. Exp. Cell Res. 314: 3027-3035.
9. Ashwell, J. D., F. W. Lu, and M. S. Vacchio. 2000. Glucocorticoids in T cell development and function. Ann. Rev. Immunol. 18: 309-345.
10. Vacchio, M. S., V. Papadopoulos, and J. D. Ashwell. 1994. Steroid production in the thymus: implications for thymocyte selection. J. Exp. Med. 179: 1835-1846.
11. Lechner, O., G. J. Wiegers, A. J. Oliveira-Dos-Santos, et al. 2000. Glucocorticoid production in the murine thymus. Eur. J. Immunol. 30: 337-346.
12. Kunicka, J. E., M. A. Talle, G. H. Denhardt, et al. 1993. Immunosuppression by glucocorticoids: inhibition of production of multiple lymphokines by in vivo administration of dexamethasone. Cell Immunol. 149: 39-49.
13. Almawi, W. Y., H. N. Beyhum, A. A. Rahme, and M. J. Rieder. 1996. Regulation of cytokine and cytokine receptor expression by glucocorticoids. J. Leukoc. Biol. 60: 563-572.
14. Franchimont, D., E. Louis, W. Dewe, et al. 1998. Effects of dexamethasone on the profile of cytokine secretion in human whole blood cell cultures. Regul. Pept. 73: 59-65.
15. Chen, X., J. J. Oppenheim, R. T. Winkler-Pickett, et al. 2006. Glucocorticoid amplifies IL-2-dependent expansion of functional FoxP3(+)CD4(+)CD25(+) T regulatory cells in vivo and enhances their capacity to suppress EAE. Eur. J. Immunol. 36: 2139-2149.
16. Vitale, C., L. Chiossone, C. Cantoni, et al. 2004. The corticosteroid-induced inhibitory effect on NK cell function reflects down-regulation and/or dysfunction of triggering receptors involved in natural cytotoxicity. Eur. J. Immunol. 34: 3028-3038.
17. Moustaki, A., K. V. Argyropoulos, C. N. Baxevanis, et al. 2011. Effect of the simultaneous administration of glucocorticoids and IL-15 on human NK cell phenotype, proliferation and function. Cancer Immunol. Immunother. 60: 1683-1695.
18. Bush, K. A., K. Krukowski, J. L. Eddy, et al. 2012. Glucocorticoid receptor mediated suppression of natural killer cell activity: identification of associated deacetylase and corepressor molecules. Cell. Immunol. 275: 80-89.
19. Krukowski, K., J. Eddy, K. L. Kosik, et al. 2011. Glucocorticoid dysregulation of natural killer cell function through epigenetic modification. Brain Behav. Immun. 25: 239-249.
20. Pazirandeh, A., Y. Xue, T. Prestegaard, et al. 2002. Effects of altered glucocorticoid sensitivity in the T cell lineage on thymocyte and T cell homeostasis. FASEB J. 16: 727-729.
21. Okret, S., A. C. Wikstrom, O. Wrange, et al. 1984. Monoclonal antibodies against the rat liver glucocorticoid receptor. Proc. Natl. Acad. Sci. USA. 81: 1609-1613.
22. Cintra, A., M. Zoli, L. Rosen, et al. 1994. Mapping and computer assisted morphometry and microdensitometry of glucocorticoid receptor immunoreactive neurons and glial cells in the rat central nervous system. Neuroscience 62: 843-897.
23. Kiessling, R., E. Klein, and H. Wigzell. 1975. "Natural" killer cells in the mouse. I. Cytotoxic cells with specificity for mouse Moloney leukemia cells. Specificity and distribution according to genotype. Eur. J. Immunol. 5: 112-117.
24. Kiessling, R., G. Petranyi, G. Klein, and H. Wigzel. 1975. Genetic variation of in vitro cytolytic activity and in vivo rejection potential of non-immunized semi-syngeneic mice against a mouse lymphoma line. Int. J. Cancer. 15: 933-940.
25. Zhou, F., B. T. Rouse, and L. Huang. 1992. Prolonged survival of thymoma-bearing mice after vaccination with a soluble protein antigen entrapped in liposomes: a model study. Cancer Res. 52: 6287-6291.
26. Powzaniuk, M. A., R. Trotta, M. J. Loza, et al. 2001. B-Myb overexpression results in activation and increased Fas/Fas ligand-mediated cytotoxicity of T and NK cells. J. Immunol. 167: 242-249.
27. Hori, S., T. Nomura, and S. Sakaguchi. 2003. Control of regulatory T cell development by the transcription factor Foxp3. Science 299: 1057-1061.
28. Fontenot, J. D., M. A. Gavin, and A. Y. Rudensky. 2003. Foxp3 programs the development and function of CD4+CD25+ regulatory T cells. Nat. Immunol. 4: 330-336.
29. Khattri, R., T. Cox, S. A. Yasayko, and F. Ramsdell. 2003. An essential role for Scurfin in CD4+CD25+ T regulatory cells. Nat Immunol. 4: 337-342.
30. Sakaguchi, S., N. Sakaguchi, M. Asano, et al. 1995. Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J. Immunol. 155: 1151-1164.
31. McHugh, R. S., M. J. Whitters, C. A. Piccirillo, et al. 2002. CD4(+)CD25(+) immunoregulatory T cells: gene expression analysis reveals a functional role for the glucocorticoid-induced TNF receptor. Immunity 16: 311-323.
32. Borsellino, G., M. Kleinewietfeld, D. Di Mitri, et al. 2007. Expression of ectonucleotidase CD39 by Foxp3+ Treg cells: hydrolysis of extracellular ATP and immune suppression. Blood 110: 1225-1232.
33. Watanabe, N., M. Gavrieli, J. R. Sedy, et al. 2003. BTLA is a lymphocyte inhibitory receptor with similarities to CTLA-4 and PD-1. Nat. Immunol. 4: 670-679.
34. Gianchecchi, E., D. V. Delfino, and A. Fierabracci. 2013. Recent insights into the role of the PD-1/PD-L1 pathway in immunological tolerance and autoimmunity. Autoimmun. Rev. 12: 1091-1100.
35. Suzuki, H., Z. Shi, Y. Okuno, and K. Isobe. 2008. Are CD8+CD122+ cells regulatory T cells or memory T cells?Hum. Immunol. 69: 751-754.
36. Hayakawa, Y., and M. J. Smyth. 2006. CD27 dissects mature NK cells into two subsets with distinct responsiveness and migratory capacity. J. Immunol. 176: 1517-1524.
37. Zhang, B., S. Kirov, and J. Snoddy. 2005. WebGestalt: an integrated system for exploring gene sets in various biological contexts. Nucleic Acids Res. 33: W741-W748.
38. Wang, J., D. Duncan, Z. Shi, and B. Zhang. 2013. WEB-based GEne SeT AnaLysis Toolkit (WebGestalt): update 2013. Nucleic Acids Res. 41: W77-W83.
39. Huang da, W., B. T. Sherman, and R. A. Lempicki. 2009. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat. Protoc. 4: 44-57.
40. Schreiber, T. H., V. V. Deyev, J. D. Rosenblatt, and E. R. Podack. 2009. Tumor-induced suppression of CTL expansion and subjugation by gp96-Ig vaccination. Cancer Res. 69: 2026-2033.
41. Sakaguchi, S., M. Miyara, C. M. Costantino, and D. A. Hafler. 2010. FOXP3+ regulatory T cells in the human immune system. Nat. Rev. Immunol. 10: 490-500.
42. Lourenco, E. V., and A. La Cava. 2011. Natural regulatory T cells in autoimmunity. Autoimmunity 44: 33-42.
43. Bahcheli, D., V. Hay, J. L. Nadeau, and C. A. Piccirillo. 2011. Transfer of cell membrane components via trogocytosis occurs in CD4+ Foxp3+ CD25+ regulatory T-cell contact-dependent suppression. Autoimmunity 44: 607-615.
44. Hussain, S., S. J. Kirwin, and S. A. Stohlman. 2011. Increased T regulatory cells lead to development of Th2 immune response in male SJL mice. Autoimmunity 44: 219-228.
45. Betts, G. J., S. L. Clarke, H. E. Richards, et al. 2006. Regulating the immune response to tumours. Adv. Drug. Deliv. Rev. 58: 948-961.
46. Zou, W. 2006. Regulatory T cells, tumour immunity and immunotherapy. Nat. Rev. Immunol. 6: 295-307.
47. Betts, G., J. Twohig, M. Van den Broek, et al. 2007. The impact of regulatory T cells on carcinogen-induced sarcogenesis. Br. J. Cancer. 96: 1849-1854.
48. Zhou, S., H. Tao, Z. Zhen, et al. 2013. Depletion of CD4+ CD25+ regulatory T cells promotes CCL21-mediated antitumor immunity. PloS One. 8: e73952.
49. Gratz, I. K., H. A. Truong, S. H. Yang, et al. 2013. Cutting edge: memory regulatory t cells require IL-7 and not IL-2 for their maintenance in peripheral tissues. J. Immunol. 190: 4483-4487.
50. Turnquist, H. R., Z. Zhao, B. R. Rosborough, et al. 2011. IL-33 expands suppressive CD11b+ Gr-1(int) and regulatory T cells, including ST2L+ Foxp3+ cells, and mediates regulatory T cell-dependent promotion of cardiac allograft survival. J. Immunol 187: 4598-4610.
51. Zhao, Z., S. Yu, D. C. Fitzgerald, et al. 2008. IL-12R beta 2 promotes the development of CD4+CD25+ regulatory T cells. J. Immunol. 181: 3870-3876.
52. Zhao, Y., H. Wang, M. Gustafsson, et al. 2012. Combined multivariate and pathway analyses show that allergen-induced gene expression changes in CD4+ T cells are reversed by glucocorticoids. PloS One. 7: e39016.
53. Chiossone, L., C. Vitale, F. Cottalasso, et al. 2007. Molecular analysis of the methylprednisolone-mediated inhibition of NK-cell function: evidence for different susceptibility of IL-2- versus IL-15-activated NK cells. Blood 109: 3767-3775.